Literature DB >> 30633590

The impact of perampanel and targeting AMPA transmission on anti-seizure drug discovery.

Simona Lattanzi1, Pasquale Striano2.   

Abstract

Entities:  

Year:  2019        PMID： 30633590     DOI： 10.1080/17460441.2019.1566318

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN： 1746-0441            Impact factor:   6.098


× No keyword cloud information.
  5 in total

1.  Efficacy and Safety of Epilepsy Surgery for Older Adult Patients with Refractory Epilepsy.

Authors:  Naoki Ichikawa; Ayataka Fujimoto; Tohru Okanishi; Keishiro Sato; Hideo Enoki
Journal:  Ther Clin Risk Manag       Date:  2020-03-25       Impact factor: 2.423

2.  Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures.

Authors:  Andras Fogarasi; Robert Flamini; Mathieu Milh; Steven Phillips; Shinsaku Yoshitomi; Anna Patten; Takao Takase; Antonio Laurenza; Leock Y Ngo
Journal:  Epilepsia       Date:  2020-01-07       Impact factor: 5.864

3.  Sensing the Anti-Epileptic Drug Perampanel with Paper-Based Spinning SERS Substrates.

Authors:  Andrea Macrelli; Nicolò Simone Villa; Andrea Lucotti; David Dellasega; Paolo Maria Ossi; Matteo Tommasini
Journal:  Molecules       Date:  2021-12-22       Impact factor: 4.411

4.  The Novel Direct Modulatory Effects of Perampanel, an Antagonist of AMPA Receptors, on Voltage-Gated Sodium and M-type Potassium Currents.

Authors:  Ming-Chi Lai; Ray-Chang Tzeng; Chin-Wei Huang; Sheng-Nan Wu
Journal:  Biomolecules       Date:  2019-10-22

5.  PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice.

Authors:  Vicente Villanueva; Wendyl D'Souza; Hiroko Goji; Dong Wook Kim; Claudio Liguori; Rob McMurray; Imad Najm; Estevo Santamarina; Bernhard J Steinhoff; Pavel Vlasov; Tony Wu; Eugen Trinka
Journal:  J Neurol       Date:  2021-08-24       Impact factor: 4.849
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.